MMR (Measles, Mumps and Rubella) Vaccine
14 Sept 2026 · 8 min read

On this page24 sections
The MMR vaccine is a safe and highly effective combined vaccine that protects against three serious and extremely infectious viral conditions:
Measles
Mumps
Rubella (German Measles)
Unvaccinated individuals can easily contract and spread these viruses, which can lead to severe health complications such as meningitis, hearing loss, and problems during pregnancy. Receiving two doses of the vaccine provides the highest level of long-term protection.
Childhood Vaccination Schedule in Ireland
The MMR vaccine is a routine part of Ireland's childhood immunisation programme:
Dose 1: Administered by your GP when the baby reaches 12 months of age (requires verbal parental consent at the appointment).
Dose 2: Administered at school when the child is 4 to 5 years old (Junior Infants). A written consent form will be sent home in your child's school bag weeks prior to the vaccination date.
Geographic Exception: In Donegal, Sligo, and Leitrim, Dose 2 is administered by a GP rather than a school team.
Catch-Up and Missed Doses
While getting vaccines on time is best, children can catch up if they miss a scheduled date:
If a child misses Dose 1 at 12 months, ask your GP for a catch-up appointment. They can still receive Dose 2 at school as normal.
For children age 5 or older who missed either dose, contact your GP or local health office to arrange a catch-up schedule.
Travel Requirements for Babies
Infants aged 6 to 11 months can receive an early MMR vaccine if they are travelling to a country with high measles rates or ongoing outbreaks:
Availability: Free of charge from your GP. Schedule it at least 2 weeks before departure.
Important Rule: This early dose does not replace the standard schedule. The child will still require their two regular doses at 12 months and at 4 to 5 years old.
Note: Babies under 6 months cannot receive the vaccine but retain maternal antibodies passed down during pregnancy.
MMR for Older Children and Adults
Any person who has not received two historical doses of the MMR vaccine is eligible to get vaccinated. (Individuals born in Ireland before 1978 are generally assumed to have natural immunity to measles and may not need it).
It is highly recommended to seek vaccination if you:
Are under 25 years old.
Live in shared, crowded accommodation.
Live with vulnerable people who cannot be vaccinated (e.g., infants under 1 year, pregnant women, or immunosuppressed individuals).
Were born outside of Ireland and lack documented measles immunity.
Work as a healthcare professional with direct patient contact.
Plan to travel to regions experiencing measles outbreaks.
Plan to get pregnant (you must ensure you avoid conceiving for 1 month after receiving the vaccine).
Note: If you cannot find your childhood vaccination records, receiving the MMR vaccine again is completely safe and will not cause harm.
Consent for Older Children
Anyone under the age of 16 must be accompanied to their clinic appointment by a parent or legal guardian to provide in-person consent for each individual dose.
Contraindications and Delays
Who Should Not Get the Vaccine
Do not receive the MMR vaccine if you:
Have had a severe life-threatening allergic reaction (anaphylaxis) to a previous dose of the MMR vaccine, to neomycin, or to any vaccine ingredients (such as gelatin).
Are currently pregnant.
Have a severely weakened immune system (e.g., undergoing active chemotherapy).
When to Postpone the Vaccine
You should delay your scheduled vaccination if you:
Are currently ill with a high fever (wait until you have fully recovered).
Received a varicella (chickenpox) vaccine within the last 4 weeks.
Recently received a blood transfusion or blood products.
Are taking high-dose corticosteroids (steroids) or undergoing radiotherapy.
Were exposed to specific maternal antibody treatments (like infliximab) during pregnancy or breastfeeding. Consult your specialist for appropriate baby vaccination timing.
Administration and Effectiveness
Delivery: Given as a single injection into the muscle of the upper arm or thigh.
Observation: Patients must wait in the clinic for 15 minutes post-injection to monitor for immediate reactions (30 minutes if you have a history of severe allergies).
Onset: Protection begins within 2 weeks of the injection.
Efficacy Rates: After completing both doses, approximately 99% of people are protected against measles and rubella, and 88% are protected against mumps. If a vaccinated person does contract mumps, their symptoms are significantly milder, and hospitalisation risks are extremely low.
Side Effects
Because the single injection contains three separate vaccines, mild side effects can occur at varying times. The benefits of protection far outweigh these brief risks.
Injection Site: Soreness, redness, or mild swelling at the needle site lasting 2 to 3 days.
General Malaise: Babies or young children may develop a temporary high temperature or feel unsettled for 2 to 3 days, usually appearing 7 to 11 days post-vaccine.
Condition-Specific Side Effects (Non-Infectious)
Measles component (6–10 days post-vaccine): A very mild, non-contagious form of measles featuring a rash, fever, and loss of appetite for 2 to 3 days.
Mumps component (3–4 weeks post-vaccine): About 1 in 50 children develop mild, non-contagious swelling of the glands in the cheeks, neck, or jaw lasting up to 2 days.
Rubella component (1–3 weeks post-vaccine): Some adult women experience joint pain, stiffness, or swelling for up to 3 days.
Rare Complications
Idiopathic Thrombocytopenic Purpura (ITP): In rare instances (1 in 24,000 doses), a temporary rash of bruise-like spots can develop about 2 weeks post-vaccine due to the rubella component. This condition typically resolves on its own without medical treatment, but you should contact your GP immediately for a professional evaluation if these spots appear.
Seizures and Severe Reactions
Febrile Seizures (Fits)
The Cause: A temporary high temperature triggered by the measles component of the vaccine can occasionally cause a febrile seizure. This typically occurs between 6 and 11 days following vaccination.
The Risk: This reaction is rare, occurring in approximately 1 in every 1,000 doses administered.
Comparison: The risk of experiencing a seizure due to a natural measles infection is significantly higher than the risk associated with the vaccine.
Allergic Reactions (Anaphylaxis)
Severe allergic reactions to the MMR vaccine are extremely rare. If anaphylaxis does occur, it almost always manifests within minutes of receiving the injection.
Clinical Response: Medical vaccinators are fully trained to recognize and immediately treat acute allergic reactions. Fast clinical intervention ensures a complete recovery.
Medical Screening: You must inform your doctor or nurse prior to vaccination if you or your child have a history of severe allergic reactions to gelatin or the antibiotic neomycin.
🚨 Emergency Action Required
Seek immediate medical attention if you or your child experience any of the following symptoms shortly after vaccination:
Difficulty breathing or wheezing
Sudden dizziness or lightheadedness
A rapid heartbeat
A widespread, sudden skin rash
Safety and Vaccine Ingredients
The two primary brands of the MMR vaccine utilized in Ireland are Priorix and MMRVaxPro.
Active Components: The main ingredient consists of small, highly weakened amounts of the live measles, mumps, and rubella viruses. These teach the immune system how to fight the actual diseases.
No Mercury: The MMR vaccine does not contain thiomersal (mercury).
Egg Allergies: The MMR vaccine is entirely safe for individuals with severe egg allergies. The vaccine viruses are cultured on chick embryo cells, not on the egg white or yolk.
Porcine Gelatin: The MMRVaxPro brand contains porcine (pig-derived) gelatin, which acts as a stabilizer to keep the vaccine safe and effective during storage.
Religious Rulings on Porcine Gelatin
The use of vaccines containing porcine gelatin is officially permitted under both Islamic and Jewish dietary and religious laws, as it is considered a life-saving medical product rather than ingested food. Official guidance includes:
The Irish Council of Imams endorsement statement.
Direct rabbinical confirmation letters.
Note: You can review a complete, detailed list of all stabilizing ingredients in the specific patient information leaflet provided at the clinic.
The MMR Vaccine is Not Linked to Autism
Extensive, worldwide medical research and rigorous scientific studies involving millions of children have repeatedly investigated this claim. There is absolutely no scientific evidence linking the MMR vaccine to autism. The vaccine remains safe, rigorously tested, and critical for public health.
Disclaimer
The information provided here is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional or your GP for specific medical concerns, diagnoses, or health advice. Never disregard professional medical advice or delay seeking it because of information you have read here.
